GSDME, a newly identified tumor suppressor, modulates its induced focal death in a phosphorylation-dependent manner (Zhang et al., 2020), which enhances the anti-tumor immune response (Wang et al., 2020). The gene discussed is GSDME; the disease is neoplasm.